Interv Akut Kardiol. 2008;7(1):17-20

Catheter ablation of paroxysmal atrial fibrillation using a Cooled-tip electrode

Jan Chovančík, Martin Filala, Dorota Wojnarová, Henryk Szymeczek, Radek Neuwirth, Renáta Nevřalová, Otakar Jiravský, Marian Branny
Kardiocentrum Nemocnice Podlesí, Třinec

Methods: Catheter ablation of symptomatic paroxysmal AF was carried out in 291 patients (73 females, 55 ± 10 years). The ablation strategy was based on conventional or electroanatomically navigated ablation around pulmonary veins (PV), and possibly left atrial linear lesions. PV isolation in all patients, and termination of an ongoing AF in some patients, were the endpoints of the procedure.

Results: Repeat ablation was performed in 60 (21 %) patients; 17 (6 %) patients, and 2 (1 %) patients underwent two, respectively three repeat ablations. There were 4 significant periprocedural complications (1.4 % per patients, 1.1 % per procedures). At the end of the 22 ± 14 month follow-up period, 250 (86 %) patients remained free from clinically obvious AF recurrence, of whom 207 (71 %) had no documentation or clinical suspicion of AF recurrence free from antiarrhythmic drugs. Reduction in the use of amiodarone (119 vs. 23 patients), propafenone (101 vs. 25 patients) a sotalol (58 vs. 19 patients), and warfarin (271 vs. 61 patients) was significant (P < 0,001 for all drugs).

Conclusion: Long-term success of catheter ablation of paroxysmal AF using a cooled-tip electrode is high. Reduction in the use of antiarrhythmic medication and warfarin is significant.

Keywords: atrial fibrillation, paroxysmal, catheter ablation, cooled-tip electrode

Published: March 27, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chovančík J, Filala M, Wojnarová D, Szymeczek H, Neuwirth R, Nevřalová R, et al.. Catheter ablation of paroxysmal atrial fibrillation using a Cooled-tip electrode. Interv Akut Kardiol. 2008;7(1):17-20.
Download citation

References

  1. Haďssaguerre M, Jaďs P, Shah DC et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 2000; 101: 1409-1417. Go to original source... Go to PubMed...
  2. Marrouche NF, Dresing T, Cole C et al. Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation. J Am Coll Cardiol 2002; 40: 464-474. Go to original source... Go to PubMed...
  3. Pappone C, Oreto G, Rosanio S et al. Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation 2001; 104: 2539-2544. Go to original source... Go to PubMed...
  4. Fiala M, Chovančík J, Heinc P, Neuwirth R, Nevřalová R, Nykl I, Branny M. Léčba symptomatické intermitentní fibrilace síní katetrovou ablací v levé srdeční síni: bezprostřední a dlouhodobé výsledky u 150 pacientů. Vnitř Lék. 2005; 51: 971-983.
  5. Haďssaguerre M, Jais P, Shah DC et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-666. Go to original source... Go to PubMed...
  6. Jaďs P, Haďsssaguerre M, Shah DC et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997; 95: 572-576. Go to original source... Go to PubMed...
  7. Ouyang F, Bänsch D, Ernst S et al. Complete isolation of the left atrium surrounding the pulmonary veins: new insights form the double-Lasso technique in paroxysmal atrial fibrillation. Circulation 2004; 110: 2090-2096. Go to original source... Go to PubMed...
  8. Pappone C, Santinelli V, Manguso F et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 2004; 109: 327-334. Go to original source... Go to PubMed...
  9. Scherlag BJ, Yamanashi W, Patel U, Lazzara R, Jackman WM. Autonomically induced conversion of pulmonary vein focal firing into atrial fibrillation. J Am Coll Cardiol 2005; 45: 1878-1886. Go to original source... Go to PubMed...
  10. Cappato R, Calkins H, Chen SA et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005; 111: 1100-1105. Go to original source... Go to PubMed...
  11. Pappone C, Augello G, Sala S et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation. The APAF study. J Am Coll Cardiol 2006; 48: 2340-2347. Go to original source... Go to PubMed...
  12. Fiala M, Chovančík J, Moravec R et al. Recidivující arytmie po katetrové ablaci původně paroxysmální fibrilace síní a výsledky opakované ablace. Vnitř Lék 2007; 53: 1248-1254. Go to PubMed...
  13. Nevřalová R, Fiala M, Chovančík J et al. Vliv katetrizační zkušenosti a volby ablační energie na rozvoj katetrové ablace jako rutinní metody pro intermitentní a perzistentní fibrilaci síní. Cor Vasa 2006; 48: 227-232. Go to original source...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.